Table 5.

Fivefold cross validation results shown by using CNNGLCM model on human.

Testing set	AC (%)	TPR (%)	PPV (%)	MCC (%)
1	94.05	89.16	90.69	85.79
2	95.17	90.82	90.72	84.27
3	93.22	86.22	91.29	84.88
4	93.86	87.33	90.32	82.98
5	94.37	88.28	91.46	84.47
(Average of 5 tests)	94.13 ± 0.72	88.36 ± 1.85	90.89 ± 0.36	84.48 ± 1.26